Actuate Therapeutics, Inc. (NASDAQ:ACTU – Get Free Report) saw a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 695,971 shares, a growth of 54.6% from the July 30th total of 450,180 shares. Approximately 6.9% of the shares of the company are short sold. Based [...]
Actuate Therapeutics, Inc. (NASDAQ:ACTU) Short Interest Update
